Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Valproic acid, a common antiepileptic medication, can cause reversible hair loss in patients.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Possible link between androgens and COVID-19 severity; more research needed.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Retinoic acid is not linked to hair loss from fluconazole use.

Ayurvedic treatments can effectively regrow hair in alopecia areata.

Multiple treatments work best for hair loss.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

Combining barber scalp care with medical treatment improves scalp health and well-being in early-stage alopecia.

Women with thyroid disease are more likely to experience female pattern hair loss, especially if they've had thyroid disease for a long time.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Psychotropic medications can cause skin problems but also treat some skin conditions.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Higher DHT in male baldness may protect against prostate cancer.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Molybdenum nanoparticles could be a new treatment for hair loss, working differently than minoxidil.